Portal de Periódicos da CAPES

The nose, upper airway, and obstructive sleep apnea

2015; Elsevier BV; Volume: 115; Issue: 2 Linguagem: Inglês

10.1016/j.anai.2015.06.011

1534-4436

Chelle Pope Wilhelm, Richard D. deShazo, Sadeka Tamanna, M. Iftekhar Ullah, Leigh Baldwin Skipworth,

Neuroscience of respiration and sleep

InstructionsCredit can now be obtained, free for a limited time, by reading the review article in this issue and completing all activity components. Please note the instructions listed below:•Review the target audience, learning objectives and all disclosures.•Complete the pre-test online at http://www.annallergy.org (click on the CME heading).•Follow the online instructions to read the full version of the article; reflect on all content as to how it may be applicable to your practice.•Complete the post-test/evaluation and claim credit earned; at this time, you will have earned up to 1.0 AMA PRA Category 1 CreditTM. Please note that the minimum passing score on the post-test is 70%.Release Date: August 1, 2015Expiration Date: July 31, 2017Target Audience: Physicians involved in providing patient care in the field of allergy/asthma/immunologyLearning Objectives:At the conclusion of this activity, participants should be able to:•Discuss present concepts of the role of nasal abnormalities in obstructive sleep apnea•Review clinical studies evaluating the role of rhinitis and therapy of rhinitis in obstructive sleep apneaAccreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Planning Committee Members:Richard D. deShazo, MD (Author)Jonathan A. Bernstein, MD (Annals CME Subcommittee)Guha Krishnaswamy, MD (Annals CME Subcommittee)John J. Oppenheimer, MD (Annals CME Subcommittee, Associate Editor)Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor)Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief)Disclosure of Relevant Financial Relationships:M.H. Grayson has received research grants from Children's Research Institute/Medical College of Wisconsin, Merck, National Institutes of Health (NIH), and Polyphor. G.D. Marshall has received research grants from Amgen, AstraZeneca, HRSA and National Institutes of Health (NIH). J.J. Oppenheimer has been a consultant/advisor for AstraZeneca, GlaxoSmithKline, Meda, Mylan, and Sunovion; has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis. C. Wilhelm, S. Tamanna, M.I. Ullah, R. deShazo, L Baldwin Skipworth, J.A. Bernstein, and G. Krishnaswamy, have nothing to disclose. Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device is discussed.Recognition of Commercial Support: This activity has not received external commercial support.Copyright Statement: © 2015-2017 ACAAI. All rights reserved.CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at [email protected] or 847-427-1200. Credit can now be obtained, free for a limited time, by reading the review article in this issue and completing all activity components. Please note the instructions listed below:•Review the target audience, learning objectives and all disclosures.•Complete the pre-test online at http://www.annallergy.org (click on the CME heading).•Follow the online instructions to read the full version of the article; reflect on all content as to how it may be applicable to your practice.•Complete the post-test/evaluation and claim credit earned; at this time, you will have earned up to 1.0 AMA PRA Category 1 CreditTM. Please note that the minimum passing score on the post-test is 70%. Release Date: August 1, 2015 Expiration Date: July 31, 2017 Target Audience: Physicians involved in providing patient care in the field of allergy/asthma/immunology Learning Objectives: At the conclusion of this activity, participants should be able to:•Discuss present concepts of the role of nasal abnormalities in obstructive sleep apnea•Review clinical studies evaluating the role of rhinitis and therapy of rhinitis in obstructive sleep apnea Accreditation: The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Designation: The American College of Allergy, Asthma & Immunology (ACAAI) designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Planning Committee Members: Richard D. deShazo, MD (Author) Jonathan A. Bernstein, MD (Annals CME Subcommittee) Guha Krishnaswamy, MD (Annals CME Subcommittee) John J. Oppenheimer, MD (Annals CME Subcommittee, Associate Editor) Mitchell H. Grayson, MD (CME Series Editor, Deputy Editor) Gailen D. Marshall, Jr, MD, PhD (Editor-in-Chief) Disclosure of Relevant Financial Relationships: M.H. Grayson has received research grants from Children's Research Institute/Medical College of Wisconsin, Merck, National Institutes of Health (NIH), and Polyphor. G.D. Marshall has received research grants from Amgen, AstraZeneca, HRSA and National Institutes of Health (NIH). J.J. Oppenheimer has been a consultant/advisor for AstraZeneca, GlaxoSmithKline, Meda, Mylan, and Sunovion; has received research grants from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis. C. Wilhelm, S. Tamanna, M.I. Ullah, R. deShazo, L Baldwin Skipworth, J.A. Bernstein, and G. Krishnaswamy, have nothing to disclose. Reviewers and Education/Editorial staff have no relevant financial relationships to disclose. No unapproved/investigative use of a product/device is discussed. Recognition of Commercial Support: This activity has not received external commercial support. Copyright Statement: © 2015-2017 ACAAI. All rights reserved. CME Inquiries: Contact the American College of Allergy, Asthma & Immunology at [email protected] or 847-427-1200.